Biosimilar therapeutic interchange processes can mitigate high costs of cancer drugs.
Josh Howell, PharmD, BCOP
Advertisement
Articles by Josh Howell, PharmD, BCOP
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
Inhaled Insulin Demonstrates Comparable Safety, Lung Function, and Efficacy to Injectable Insulin in Type 1 Diabetes
2
CDC Layoffs Raise Questions About the Future of Public Health Surveillance
3
From $200,000 in Student Loan Debt to Becoming a 7-Figure Pharmacist
4
Mind the Gap: Pharmacy’s Future as AI Evolves in Health Care
5
